Anavex Life Sciences Corp (AVXL)

[JB3729]

Can't we work out when the 12 wk data is due? Isn't next week the 12th week?

There have been 2 posts that gave us a good idea of the timing for Anavex to have the full top line 12 week data in hand and each one confirms the other (bold by me) -

Miss Australia Tuesday, 01/19/16 05:55:02 PM
Re: Mikesc post# 50948
Post # of 52858

Well I would say it is imminent . My family member went through their tests on the 4/5th January and as I have said before, I am pretty sure they were in the last group to start the original trial. Wasn't there another medical conference coming up soon?


bernardc Member Level Tuesday, 12/08/15 07:37:34 PM
Re: None
Post # of 46059

I went today to the presentation in DC.
Here are the highlights:
-Anavex was the only biotech presenting
-2-73 can become a potential platform for the treatment of a number of CNS diseases since recent studies found that a number of them have same origin
-the phase 2a is designed with a lot of hurdle so that phase 3 doesn't fail
-our CEO hardly discussed the 12 weeks data since it's ongoing and the only thing he mentioned was that 70% of patients noticed improvement in quality of life
-since he couldn't reveal non public info, he insisted on the fact that all patients want to go for the 52 weeks and that is very unusual
-he also insisted that at 5 weeks 2 tests showed statistically significant improvement whereas the trial was not designed to measure them. And in those tests there is not a placebo effect like testing pain for ex.
- the more data they get the more it confirms the positive results
-12 weeks result should be out by mid-january if not before and they will be looking for a great venue to announce them

Most of what was said is already public but the few new info speak for themselves

Someone asked again about the reversal in cognition as for her it's unheard of.
**********************************************************************************************************************************

Only Dr.Missling knows if he considers next week's conference to be a great venue.

I wouldn't mind seeing PART A, PK/PD data released next week and the PART B, 12 week data held for a scientific conference. This would keep a short term catalyst in play and shorten the time frame between the releases of the 12 week data and the 26 week data.